CD274 and neoplasm: Specifically, Groups 1–6 represent patient subsets stratified by two parameters: (i) tumor PD-L1 expression (TPS 0%, 1–49%, or ≥ 50%) and (ii) serum sEV PD-L1 concentrations above or below the 166 pg/mL cutoff identified in our previous study.